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Background: The mannose receptor is the best described member of the type I transmembrane C-type lectins;
however much remains unanswered about the biology of the receptor. One difficulty has been the inability to
consistently express high levels of a functional full length mannose receptor cDNA in mammalian cells. Another
difficulty has been the lack of a human macrophage cell line expressing a fully functional receptor. Commonly used
human macrophage cell lines such as U937, THP-1, Mono-Mac and HL60 do not express the mannose receptor. We
have developed a macrophage hybridoma cell line (43MR cells) created by fusion of U937 cells with primary human
monocyte-derived macrophages, resulting in a non-adherent cell line expressing several properties of primary
macrophages. The purpose of this study was to identify and select mannose receptor-expressing cells using
fluorescence-activated cell sorting and to characterize the expression and function of the receptor.
Results: In the current study we show that the mannose receptor found on this novel cell has endocytic
characteristics consistent with and similar to the mannose receptor found on the surface of monocyte-derived
human macrophages and rat bone marrow-derived macrophages. In addition, we demonstrate that these cells
engage and internalize pathogen particles such as S. aureus and C. albicans. We further establish the transfectability
of these cells via the introduction of a plasmid expressing influenza A hemagglutinin.
Conclusions: The 43MR cell line represents the first naturally expressed MR-positive cell line derived from a human
macrophage background. This cell line provides an important cell model for other researchers for the study of
human MR biology and host-pathogen interactions.Background
The mannose receptor (MR) is a 175 kDa type I trans-
membrane protein that was first described by Stahl and
coworkers as a cell surface receptor involved in the
clearance of extracellular hydrolases [1]. Since that time
many more roles have been ascribed to the MR includ-
ing clearance of pathogens [2], capture of foreign anti-
gens for presentation to MHC-II compartments [3,4],
clearance of glycoprotein hormones [5], clearance of
extracellular peroxidases [6,7], endocytosis of lysosomal
acid phosphatase [8], and regulation of glycoprotein
homeostasis [9]. Recent work has suggested that the MR
may serve as an entry receptor for several important
human pathogens [10-14]. In addition to a cysteine-rich* Correspondence: Virginia.l.shepherd@vanderbilt.edu
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reproduction in any medium, provided the ordomain and fibronectin type II repeat, the MR structur-
ally contains eight carbohydrate recognition domains
(CRD), of which 4, 5 and 7 are reported to be the most
critical for binding and internalization of ligands with
exposed oligosaccharides terminating in mannose,
fucose or N-acetylglucosamine [15].
A characteristic feature of the MR and other members
of this family is their rapid internalization from the
plasma membrane via a clathrin-mediated mechanism
that delivers the receptors to the endocytic pathway
[16,17]. Several studies have shown that the MR binds
and internalizes ligands via receptor-mediated endocyto-
sis [18,19], and participates in phagocytosis of mannosy-
lated particles and pathogens [20,21]. Mannosylated
ligands bind to the MR at the cell surface at neutral pH
and are brought into the cell, where they dissociate from
the receptor in an acidic endosomal compartment
[22,23]. Ligands are then transported to the lysosome for
degradation. Degraded particles are either packaged intol Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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media by exocytosis [24]. It has been reported that 10-
30% of the receptor at steady state resides on the cell
surface and the remaining 70-90% is located in an intra-
cellular pool. The MR has a long half-life (>30 hours),
and makes 10 or more rounds of recycling each
hour [25].
In addition to endocytic properties, several members of
the MR family of molecules participate in phagocytosis, a
function vital to the role of the macrophage in the innate
immune response. Macrophages are found in virtually all
tissues and are among the first cells to encounter an in-
vading microorganism. The recognition capacity of the
MR is broad allowing for the capture and uptake of a var-
iety of pathogens including Paracoccidioides brasiliensis
[26,27] Candida albicans [28], Leishmania donovani
[29], Mycobacterium tuberculosis [30,31], Pneumocystis
jirovecii (formally Pneumocystis carinii sp. hominis) [32],
Klebsiella pneumoniae [33], HIV [11,34], Dengue [35],
Hepatitis B [36], and influenza A [10,37]. Mannose is not
often found as a terminal residue on the cell surface of
mammalian-derived proteins, but is commonly found on
the surface of a variety of pathogens, thus allowing
the MR to distinguish self from non-self through
carbohydrate recognition.
Expression and function of the MR is tightly linked to
the activation state of the macrophage and a variety of
cytokines and chemical messengers are involved in the
regulation of the MR. For example, interleukin (IL)-4,
IL-10, IL-13 and prostaglandin E2 (PGE2) are known to
up-regulate the expression of the MR [38-41], as does
exposure to dexamethasone and vitamin D3 [42-44].
Proinflammatory cytokines that activate macrophages at
sites of inflammation such as interferon (IFN)-γ down-
regulate MR expression [45]. Exposure to pathogens
such as Leishmania, C. albicans, bacillus Calmette-
Guerin, HIV-1, and influenza likewise down-regulate
receptor expression [46,47]. This complex system of
regulation is critical to the role that the MR plays in the
resolution of inflammation, allowing for efficient re-
moval of harmful extracellular enzymes such as myelo-
peroxidase, eosinophil peroxidases, tissue plasminogen
activator, and lysosomal hydrolases [6]. Further support
for an in vivo role for the regulation of extracellular gly-
coproteins has come from studies with MR null mice
that showed that the lack of MR results in decreased
clearance of hydrolases and procollagens [9].
To date there are very few macrophage cell lines that
express a functional MR. Commonly used human macro-
phage cell lines such as U937, THP-1, Mono-Mac and
HL60 do not express the MR. Those cell lines that have
been described as MR-positive are of murine or rat deriv-
ation [45,48,49]. In particular the MR-positive murine
J774E and rat NR8383 cell lines have been extensivelyused in studies of MR function but until the current
study there has been no available continuous human
macrophage cell line that expresses the MR.
The MR has been implicated as a potential entry re-
ceptor for a variety of pathogens, and a target for regula-
tion by human pathogen-associated proteins suggesting
relevance for this receptor in the context of human dis-
ease [10,11,50]. Additionally, the glycosylation profile of
many human pathogens makes uptake via the MR likely
[37,51-53]. In the current study we have characterized
and cultivated a human hybridoma cell line that
expresses MR. The utility of a human macrophage cell
line and expression system for the MR will allow further
study of MR biology and characterization of host-
pathogen interactions between macrophages and causa-
tive agents of infectious disease. These tools will allow
for further study of the biology and trafficking of the
MR within the cell.
Methods
Cells
Macrophages used in this study included rat bone
marrow-derived macrophages (RBMM), U937, and the
continuous human macrophage hybridoma cell line 43
(obtained from Dr. K. Sperber, Mt. Sinai Medical Cen-
ter), generated by fusing the hypoxanthine-guanosine
phosphoribosyltranferase-deficient promonocytic cell
line, U937, with human monocyte-derived macrophages
(MDM). Fusion was documented by the acquisition of
donor class I molecules [54]. U937, 43 parental cells,
and 43MR cells were maintained in RPMI 1640 with 10%
FBS and antibiotics. RBMM were prepared from bone
marrow obtained from Sprague–Dawley rats as previ-
ously described [55,56] and maintained in RPMI with
10% FBS and antibiotics.
Plasmids and antibodies
The polyclonal antibody used in immunoblot analysis
for the detection of MR was prepared in our laboratory
[49]. Monoclonal antibody against the human MR was
obtained from BD Biosciences as an unlabeled antibody
and also directly conjugated to Alexa 488 (San Jose CA).
Mouse anti-hemagglutinin (HA) directly conjugated to
Alexa 488 was obtained from Invitrogen (Carlsbad CA).
Anti-EEA1 monoclonal antibody was obtained from BD
Biosciences (San Jose CA). Antibodies conjugated to
Alexa dyes (488, 555, and 568) for use in cytometry
studies were obtained from Invitrogen (Carlsbad CA).
Phycoerythrin (PE)-conjugated antibodies for use in
fluorescent-activated cell sorting (FACS) were purchased
from BD Biosciences (San Jose CA). Influenza PR8 HA
plasmid was obtained from Adolfo Garcia-Sastre (Mt.
Sinai Medical Center) and used for transfection assay to
determine the capacity and efficiency of transfection.
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To determine the efficiency of transfection, 43MR cells
were transfected with Fugene (Roche) at a ratio of 6:1
according to manufacturer directions. Cells at 1 x 106
cells per well were plated into 6-well tissue culture
dishes and transfected with 5 μg of PR8 HA plasmid.
Cells were incubated at 37°C for 24 hours, and then har-
vested for flow cytometry as previously described.
Flow cytometry and confocal microscopy
Flow cytometry was performed using a FACSCaliber
(BD Biosciences, San Jose CA) bench top analyzer in the
VA and Vanderbilt cytometry core facilities. Cells were
stained with PE-conjugated antibodies against MR as fol-
lows: cells were collected by centrifugation, followed by
suspension in staining buffer (1% BSA, 0.1% sodium
azide, 0.5% normal goat serum in PBS). 10% normal goat
serum was included in the stain buffer to saturate Fc
receptors and minimize non-specific fluorescence.
PE-conjugated antibody was diluted in staining buffer
and added to the cells. Additionally, an isotype matched
control was also performed to account for non-specific
fluorescence, and an unstained sample was included to
account for autofluorescence. The cells were incubated
for 20 minutes in the dark at 4°C. The cells were washed
twice with staining buffer followed by fixation in 500μl of
2% buffered paraformalin. The modulation of cell surface
receptor density was represented as the percent change
in mean fluorescence intensity as compared to the con-
trol. The number of events acquired for each sample was
3 x 104 and cells were analyzed on a Becton Dickinson
FACScan flow cytometer using CellQuest software or
WinMDI FACS analysis software from J. Trotter (Scripps
Research Institute, La Jolla CA). Characterization of the
cell surface expression profile of the 43MR cells was per-
formed by flow cytometry using antibody against typical
macrophage surface expressed molecules (HLA ABC,
CCR5, CD32, CD64, CD4, CD14, transferrin, DC-
DSIGN, CXCR4, CD80, CD86, CD11) obtained from BD
Biosciences (San Jose, CA). Confocal microscopy was
performed using a Zeiss LSM-510 laser scanning inverted
microscope. Cells were fixed in 2% buffered paraformalin
followed by permeabilization with ice cold methanol. Fol-
lowing fixation and permeabilization, cells were stained in
two ways. First, a two-step process using mouse monoclo-
nal anti-MR antibody (BD Bioscience, San Jose CA) fol-
lowed by either goat anti-mouse Alexa-488 or Alexa-568
(Invitrogen, Carlsbad CA) secondary. Second, a custom
mouse monoclonal antibody against MR directly conju-
gated to Alexa 488 was also used. This second method
eliminates the potential problem of non-specific secondary
binding. Nuclei were stained for visualization with TO-
PRO-3 (Invitrogen, Carlsbad CA). Cells were mounted in
Aqua-polymount (Polysciences, Warrington PA) betweencoverslips. Images were collected at 520 nm using a 63x
oil-immersion objective. Image processing was performed
using Adobe Photoshop CS imaging software.
Phagocytosis assay
Phagocytosis was assayed via uptake of pHrodo BioParti-
cles (Invitrogen, Eugene, OR). pHrodo S. aureus BioPar-
ticles conjugates are novel, no-wash fluorogenic particles
used for quantitative measurement of phagocytosis.
Since the fluorescent intensity of the bioparticle is tightly
linked to the pH of the environment, particles in the
extracellular environment typically display little to no
fluorescence. The resulting fluorescence can therefore
be attributed to internalized particles. Cells were cul-
tured in complete media at a concentration of 5 x 105 in
6-well tissue culture dishes. After 24 hr, BioParticles pre-
pared according to the manufacturer’s instructions were
added to cells, and the plates incubated at 37°C for
30 minutes to allow for uptake. Cells were washed to re-
move unattached BioParticles, followed by fixation in 2%
paraformalin and staining with anti-MR Alexa-488 con-
jugated antibody, and then visualized by confocal mi-
croscopy. In addition to examining the phagocytosis of
labeled S. aureus, uptake of GFP-Candida was also
employed. GFP-Candida was provided by L. Hoyer
(U of Illinois) and incubated with cells in a 5:1 ratio at
37°C for 30 minutes. Samples were examined by con-
focal microscopy using anti-MR Alexa 568- or Alexa
555-conjugated antibody as described above.
Imunoprecipitation and immunoblot analysis
Cells (5 x 105) were lysed in lysis buffer containing 0.5%
NP-40 or 0.1% Triton. Total cellular protein was deter-
mined either by bicinchoninic acid (BCA) protein assay
(Pierce, Rockford IL) or by NanoDrop spectrophotometer
(Thermoscientific) and 10-25 μg of total protein was
resolved by electrophoresis on a 7.5 or 10% SDS-PAGE
gel. Proteins were transferred to nitrocellulose followed by
blocking in Tris-buffered saline (TBS) containing 0.1%
Tween (TBST) and 5% powdered milk. Proteins were
visualized on radiographic film using primary antibodies
to the desired protein, horseradish peroxidase (HRP)-
conjugated secondary antibodies, and chemiluminescence
reagent. Immunoblot analysis was also performed on the
Licor Odyssey platform using a goat anti-MR antibody fol-
lowed by donkey anti-goat Ir-680 dye and a mouse anti-
actin antibody followed by a donkey anti-mouse Ir-800
dye (Lincoln NE). For immunoprecipitation, cells were
seeded into 6-well dishes at 5 x 105 cells per well and
treated accordingly. Cells were lysed in 0.5% NP-40 lysis buf-
fer and lysate was precleared with protein A-Sepharose over-
night at 4°C followed by immunoprecipitation using rabbit
polyclonal antibody against MR. The immunoprecipitated
receptor was detected by immunoblot analysis after
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were visualized by chemiluminescence and exposure of
Kodak Bio-MAX film. The density of the bands was quanti-
fied using the UN-SCAN IT densitometry software from
Silk Scientific (Orem UT).Receptor internalization
Receptor internalization was assessed using FITC-Man-
BSA, FITC-BSA or fluorescent-labeled antibodies in the
following manner: triplicate samples of 5 x 105 cells were
pelleted in 12 x 75 mm Falcon tubes (Becton Dickinson
Labware, Franklin Lakes NJ), washed twice in cold PBS
to remove all media, and repelleted. The cells were
placed on ice and a 1:100 dilution of anti-human MR
conjugated to PE in cold staining buffer was used to re-
suspend the cells. Cells were incubated on ice for 15 min.
Cells were washed twice in cold PBS and samples were
taken to represent the total binding. Cells were then
warmed to 37°C and triplicate samples were taken at 0,
10, 20, 30 minutes and placed on ice. Cells were pelleted
and fixed in 500 μl cold 2% paraformalin containing 0.1%
trypan blue to quench extracellular fluorescence. Cells
were then analyzed by flow cytometry for total fluores-
cence. Fluorescence representing surface MR was plotted
versus time to determine receptor internalization.Uptake of horseradish peroxidase (HRP)
To measure ligand internalization, 10 μg of HRP was
incubated with 43MR cells (5 x 105) in 400 μl Hanks’
balanced salt solution (HBSS) containing 1% BSA
(binding buffer) as described previously [57,58]. To
control for non-specific uptake, yeast mannan (Sigma,
St. Louis MO) was added at 1 mg/ml to companion
wells as a competitor to HRP. Cells were incubated for
60 minutes at 37°C. Following incubations, the cells
were washed twice in HBSS and solubilized in 250 μl of
0.1% Triton X-100. Cell-associated activity was deter-
mined by quantifying the oxidation of phenol red in the
presence of hydrogen peroxide. HRP activity was then
normalized to total cellular protein as measured by the
BCA protein assay.Ligand binding
Binding of fluorescein isothyocyanate mannosylated-BSA
(FITC-Man-BSA)
FITC-Man-BSA and FITC-BSA (20 μg) (E-Y laboratories,
San Mateo CA) was incubated with 43MR cells (1 x 106)
in 100 μl of staining buffer in the presence or absence of
1 mg/ml mannan. Incubations were done in triplicate
and were incubated on ice for 30 minutes. Following in-
cubation, cells were washed twice in cold staining buffer,
fixed in 2% paraformalin and analyzed by flow cytometry.Binding of 125 I-mannosylated-BSA binding (125I-Man-BSA)
Man-BSA was iodinated to a specific activity of 2 x
108 cpm/μg as previously described [19]. Cells (5 x 105)
were incubated with 125I-Man-BSA in 100 μl of binding
buffer in the presence or absence of yeast mannan for
60 minutes on ice. Cell-associated counts were separated
from unbound ligand via centrifugation through mineral
oil, and cell-associated ligand was quantified by gamma
counting.Immunoprecipitation of 35S-labeled receptor
Cells were seeded into 6-well dishes at 5 x 105 cells per well
and labeled by incubation with 100 μCi of 35S-methionine
(Amersham, Piscataway NJ) in methionine-free DMEM
overnight. Labeled receptor was immunoprecipitated using
polyclonal anti-MR antibody as previously described [59].
The immunoprecipitated receptor was analyzed on 7.5%
SDS-PAGE gels. Bands were visualized by exposure of
Kodak Bio-MAX film. The density of the bands was quanti-
fied using a scanner and UN-SCAN IT densitometry
software.Reverse transcriptase-polymerase chain reaction (RT-PCR)
analysis of MR cDNA
RT-PCR of the 650 bp fragment was performed with a
sense primer derived from rat and murine cDNA. The
primer sequences were as follows: sense oligonucleotide
(S3): 5’-GCTCTAGAATGGAACACACACTCTGGGC-
CATG-3’, antisense oligonucleotide (650AS): 5’-TACCA-
CTTGTTTTCAAACTTGAA-3’. RT-PCR of the 300 bp
cytoplasmic tail fragment (TMC) was performed with
sense and antisense primers derived from the rat MR
cDNA: sense oligonucleotide (TMCR): 5’-GAGACAGT-
CAGATTAGGATGGCTAA-3’ antisense oligonucleotide
(TMCL): 5’-AAAGCTGACCAAAGGAAGATG-3’. PCR
reaction conditions were as follows: total RNA was
obtained from cell populations using Trizol and reverse
transcribed using the First-Strand cDNA synthesis kit
(Pharmacia, Piscataway, NJ). The PCR reaction mixture
contained 1 μl of MR primer (100 ng/μl); 1 μl of a
20 mM dNTP solution; 5 μl of 100 mM Tris buffer with
15 mM MgCl2 and 500 mM KCl (pH. 8.3); 1 μl of tem-
plate cDNA; 1 μl of Taq DNA polymerase (Promega);
and 40 μl of diethlypyrocarbonate (DEPC) treated water.
Thirty cycles of amplification were performed in a
Hybaid OMN-E thermocycler (MR 650: 5 minutes at
92°C, 30 seconds at 92˚, 30 seconds at 48°C, and 1 mi-
nute at 68°C; MR TMC: 5 minutes at 95°C, 1 minute
at 95°C, 1 minute at 55°C, and 1 minute at 72°C). Ali-
quots of the PCR reactions were then analyzed on
agarose gels, and bands were visualized by ethidium
bromide staining.
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Statistics were performed using Prism 5 (GraphPad Soft-
ware). For experiments involving two comparisons, a
paired Student’s two-tailed t-test was used. For experi-
ments involving in excess of two comparisons, a one
way ANOVA with post-test was performed. Significance
was determined by p values less than 0.05. All experi-
ments presented are representative of at least 3 determi-
nations with error bars that represent the standard
deviation unless otherwise noted in the figure legends.
Results
Selection of MR-positive 43 cells
MR-positive 43 cells (43MR) were selected as described
below. Upon initial analysis the parental 43 cells were
negative for MR expression. For induction of MR ex-
pression, cells were cultured in an equal mix of fresh
and spent/conditioned media (RPMI 1640 plus 10%
FBS) over a 12 month period. During this period, cells
were harvested and repeatedly sorted for MR expres-
sion and MR negative cells were discarded. The result-
ing cell line – greater than 95% MR positive - was
termed 43MR. Figure 1 shows a typical FACS analysis
and western blot of MR expression during the selection
process. Mean fluorescent intensity of 43MR increased
by 7-fold over 43 cells. Protein lysate was analyzed for
MR expression (red) and also was analyzed for the ex-
pression of a loading control. The β-actin band (green)
is seen clearly in the 43MR and U937 lanes but not as
clear in the 43neg cells. We have performed nearly a
dozen immunoblot assays using both β-actin and
GAPDH as loading controls. Although these are com-
monly used for loading controls, there are data to sug-
gest that these proteins are not ideal in many situations
[60] and a total protein approach is more appropriate.
We have run a constant amount of total protein in our
immunoblot. Data presented here shows β-actin bands
in all three lanes but not at the same intensity. This
was also the case with GAPDH. Although the intensity is
not identical we feel that the wells were equally loaded
and accurately reflect the content of the protein lysate.
Cell surface expression characteristics of the 43MR
macrophage hybridoma cell line
Macrophages express a variety of cell surface molecules
that participate in the identification and removal of intra-
cellular and extracellular molecules. However, surface ex-
pression in cell lines varies, and can be quite different
from primary macrophages. To determine the cell sur-
face profile of 43MR cells, cells were stained with a variety
of common macrophage cell markers. Table 1 shows the
cell surface expression profile of the parent 43, 43MR,
U937, and primary MDM. Similar to primary macro-
phages, 43MR cells expressed HLA ABC, CCR5, CD32and CD64, and was the only cell line expressing the MR.
It should be noted that 43MR cells do not express CD80,
CD86, DCSIGN, or CXCR4, all of which are expressed at
low levels by MDM but are not present on U937 cells,
suggesting that during the fusion process these specific
cell surface proteins were not induced. Figure 1 demon-
strates the surface profile by FACS analysis of 43 negative
parental cells (43neg), U937 and the 43MR cells. Figure 1
further shows by Western blot that the U937 and 43neg
cells are negative for MR expression while the 43MR cells
show a strong band at approximately 175 kDa.
Expression of the MR protein by 43MR Cells
Expression of the MR protein was determined by con-
focal microscopy and immunoblot analysis to corrobo-
rate the flow cytometry data showing cell surface
expression of the MR. Whole cell lysate (10 μg) from
43MR cells and control RBMM was resolved by SDS-
PAGE electrophoresis. Confocal microscopy demon-
strated that the MR protein resides on the surface as well
as in discrete intracellular compartments where it loca-
lizes with EEA1 consistent with the description of MR in
primary macrophages (Figure 2A). Co-localization with
EEA1 indicates that the MR is trafficking thru endosomal
compartments. For immunoblot analysis, whole cell lys-
ate (10 μg) from 43MR and control RBMM was resolved
by SDS-PAGE electrophoresis. Using a polyclonal anti-
body generated in our laboratory from human placenta,
results showed a 175 kDa band (Figure 2B), with expres-
sion of the MR in 43MR cells approximately 10-fold less
than control RBMM by densitometric scanning. This
level of MR expression in 43MR cells compared to RBMM
(1:10) is in agreement with estimates of levels of the MR
in primary human macrophages [61]. The affinity of this
antibody for human, mouse and rat MR has been tested
in our laboratory and we find that the antibody equally
recognizes MR from these different species.
Reverse transcriptase polymerase chain reaction (RT-PCR)
Expression of MR mRNA was assessed by RT-PCR using
oligonucleotides derived from the rat MR cDNA se-
quence [49]. The primers used generated an internal
650 bp fragment within the extracellular region of the
MR and a 300 bp fragment from the C-terminal end of
the cytoplasmic tail of the MR. Figure 2C demonstrates
that both a 650 bp and 300 bp fragment was seen in the
43MR cells, consistent with previously published data
from RBMM [49], and was not detected in parental 43
cells (data not shown).
Mannose receptor turnover in 43MR cells
In this study we have shown by FACS that the MR is
expressed on the surface of 43MR cells and that the recep-
tor is the same molecular weight as the MR from RBMM
Figure 1 Flow cytometric analysis of parental and MR-positive Cells. 43, U937 and 43MR cells were harvested and prepared for Western blot
and flow cytometric (FACS) analysis. For FACS analysis, cells (1 x 106) were harvested and fixed in 2% paraformalin. As negative controls, both 43
and 43MR cells were stained with Alexa 488 alone (upper right histogram) or unstained (upper left histogram). For detection of MR, 43 cells or
43MR cells were stained with mouse monoclonal anti-MR followed by Alexa 488 conjugated goat anti-mouse secondary as previously described.
The number of events acquired for each sample was 3 x 104. Data shown are the relative change in mean fluorescence intensity as compared to
the control, and data are representative of at least two independent experiments. For Western blot analysis, 1 x 106 cells were lysed in 0.1%
Triton lysis buffer and 25 μg of total protein was separated by SDS gel electrophoresis. Proteins were transferred to nitrocellulose and the blot
probed with goat anti-MR and mouse anti-actin antibodies followed by Licor donkey anti-goat Ir-680 and donkey anti-mouse Ir-800 conjugated
secondary antibodies.
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in 43MR cells, the half-life in comparison to MR turnover
in RBMM was examined. Cells were metabolically labeled
with 35S-methionine followed by immunoprecipitation
and analysis by immunoblot and densitometry. The results
indicated that the MR in 43MR cells has an approximate
half-life of 32 hours (Figure 3) which is consistent with
published data on the RBMMMR [49].Binding and uptake of ligands mediated by the MR in
43MR cells
Previous work has shown that the cell surface macro-
phage MR mediates binding and uptake of a variety ofmannose containing proteins [62-65]. To characterize
these properties of the MR in 43MR cells, binding of
125I-Man-BSA (Figure 4A), uptake of HRP (Figure 4B),
and uptake of FITC-Man-BSA and FITC-BSA (Figure 5)
was examined. An analysis of the surface binding was
performed using radiolabelled Man-BSA to determine
the level of surface expression. RBMM were used as a
control for comparison. In each case, 5 x 105 cells were
incubated with 125I-Man-BSA for 60 min at 4°C in the
presence and absence of excess mannan to determine
non-specific binding. As shown in Figure 4A, RBMM
bound approximately 60 ng versus 10 ng by 43MR cells,
suggesting that the 43MR cells express fewer receptors
on their surface. These results agree with previous
Table 1 Cell surface expression profile of macrophages
and macrophage cell lines
Marker MDM U937 43 43MR
HLA ABC +++ +++ - ++
HLA DR DQ + +++ ++ +/−
CD4 + +++ ++ +/−
CD11b + +/− n.d +/−
CD11c + - n.d +/−
CD14 +++ +++ n.d +
CD32 (FcRγIII) ++ +++ n.d +
CD36 n.d + n.d +/−
CD64 (FcRγI) + - n.d +/−
CD71 (TfR) n.d +++ n.d +++
CD80 + - ++ -
CD86 + - ++ -
CD206 (MR) +++ - - +++
DC SIGN + - n.d -
CCR5 + n.d n.d +/−
CXCR4 + + n.d -
Dectin + n.d. n.d. +
Cells (1 x 106) were harvested and stained with a variety of antibodies against
cell surface markers to determine the expression character of the 43MR cells.
Cells harvested for unstained and negative control samples were incubated
with an isotype matched control to obtain baseline fluorescence. Cells were
analyzed via FACS and scored as the percentage of positive cells above
isotype control as follows: - (0-5%), +/− (6-25%), + (26-50%), ++ (51-75%),
+++ (76-100%). n.d = not determined/unavailable. Data for macrophages can
be found reviewed in 43 cells in Sperber et al. [54] represents published cell












Figure 2 Imaging, immunoblot and RT-PCR analysis of MR
protein expression from macrophage cells. In panel A, 43MR cells
were processed for confocal imaging as described in Methods. Cells
were fixed in 2% buffered paraformalin for 15 minutes and
permeabilized in ice cold methanol for 10 minutes. Cells were then
washed and stained with mouse anti-MR directly conjugated to
Alexa 488 and rabbit anti-EEA1 antibody followed by goat
anti-rabbit Alexa 568 conjugated secondary. Nucleus was stained
with TO-PRO 3 for visual reference. (B) RBMM and 43MR cells (1 x
106) were harvested and lysed in NP-40 lysis buffer for immunoblot
analysis. Proteins (10 μg) were resolved on a 7.5% SDS-PAGE gel.
Immunoblot analysis was performed with a polyclonal antibody
against the MR and HRP-conjugated secondary antibody. Detection
of protein was performed by enhanced chemiluminescent assay and
exposure of Kodak Bio-Max scientific film. (C) Total mRNA was
prepared from 43MR cells (1 x 106) using Trizol reagent, and reversed
transcribed using the First-Strand cDNA kit. The cDNA preparations
were then subjected to PCR using the 5’ and 3’ primers described
for the 650 bp and 300 bp fragments. The data are representative of
three independent experiments.
Vigerust et al. BMC Immunology 2012, 13:51 Page 7 of 13
http://www.biomedcentral.com/1471-2172/13/51findings from our group that human macrophages have
lower surface levels of MR than murine or rat macro-
phages [61].
The MR participates in the internalization of a variety
of glycosylated proteins. HRP is a known ligand for the
MR and has been used extensively to examine the endo-
cytic capacity of the MR. To determine the endocytic ac-
tivity of the MR in 43MR cells, uptake of HRP was
measured in and compared to the uptake in RBMM,
U937 and the 43neg parental cell line in the presence
and absence of mannan. As shown in Figure 4B, 43MR
cells efficiently ingested HRP, with uptake of ~50% of
RBMM activity. The MR negative cells 43neg and U937
did not internalize a significant amount of HRP. These
results indicate that the MR in 43MR cells can mediate
uptake of traditional ligands.
Several investigators have adopted the use of flow cyto-
metry to determine the endocytic capacity of membrane-
associated receptors [66]. Results can be obtained by
using either tagged ligands or tagged antibodies raised
against the receptor. We used a FITC-labeled ligand spe-
cific (Man-BSA) for the MR to determine the level of up-
take exhibited by 43MR cells in the presence of absence ofsame specific competitor (Man). The fluorometric ap-
proach has greater sensitivity than the HRP approach
and is further improved by having a ligand with higher
avidity (Man-BSA) than HRP. Our results indicate that
approximately 60% of cells specifically internalized FITC-
Man-BSA (Figure 5). Control experiments using FITC
conjugated to a non-mannosylated BSA was also per-




































t 1/2= 32hr 
Figure 3 Mannose receptor turnover in macrophage
hybridoma cells. 43MR cells (1.5 x 107) were labeled with 1 μCi of
35S -methionine overnight in methionine-free media. Following
overnight incubation the cells were washed twice with PBS. Cells
were then resuspended in complete media and plated into 6 well
dishes. Cells were harvested at designated times and lysed in IP
buffer in preparation for immunoprecipitation. Immunoprecipitates
were resolved on a 7.5% gel and transferred to nitrocellulose.
Relative pixel intensity of bands was determined by densitometry.
Data represents the percent change in relative pixel intensity from













































Figure 4 Comparison of specific surface binding and HRP
uptake in RBMM and 43MR cells. (A) Cells (5 x 105) were incubated
on ice for 60 minutes with approximately 0.4 μg of 125I-Man-BSA in
100 μl of binding buffer in the presence or absence of mannan
(1 mg/ml). Cells with bound ligand were separated from the
unbound ligand by centrifugation thorough oil. Cell-associated
radioactivity was quantified by gamma counting. Results are
representative of three independent experiments. (B) RBMM, U937
43neg and 43MR cells were incubated with 8 μg of HRP in 400 μl of
Hanks’ balanced salt solution (HBSS) containing 1% BSA in the
presence or absence of mannan (1 mg/ml). Cells were incubated at
37°C for 60 minutes, then washed twice in HBSS and solubilized in
0.1% Triton X-100. Cell associated HRP activity was determined by
quantitation of phenol red oxidation in the presence of hydrogen
peroxide at 610 nm.
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specific for the MR as evidenced by the reduction in
internalization in the presence of excess mannan
(Figure 5).
Phagocytic activity of 43MR
Although there have been claims that the MR is not a
phagocytic receptor [67], the majority of reports suggest
that the MR is intimately involved in the binding and
internalization of particulate ligands. To examine the
phagocytosis of MR particulate ligands by 43MR cells,
cells were incubated with either pHrodo-conjugated
S. aureus or GFP-labeled-Candida. pHrodo S. aureus
particles were found to bind to the cell surface and were
internalized (Figure 6B). The cells incubated with
pHrodo labeled bacteria were found to contain between
3–20 bacterial particles per cell as determined byZ-sectioning and counting of engaged and internalized
particles. The fluorescent intensity of internalized parti-
cles increases as the pH of the intracellular compartment
increases. Figure 6A demonstrates that the much larger
yeast particle is internalized by 43MR cells; yeast particles
are clearly visualized within the cytoplasm of the cell.
Transient transfection
Primary macrophages are notoriously difficult to trans-
fect. One of the benefits to a human cell line that
expresses the MR is the use of transfection to express
proteins to study their interactions with the MR. In the
current and previous studies we have examined the effect
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Figure 5 Flow cytometric analysis of 43MR uptake of
FITC-Man-BSA. 43MR cells (1 x 106) were seeded in 6-well tissue
culture dishes and incubated with FITC-Man-BSA in the presence or
absence of excess mannan (1 mg/ml) at 37°C. Cells were also
incubated with FITC-BSA as a negative control. Following incubation,
the cells were harvested and fixed in 2% paraformalin for FACS. Cells
were also harvested for unstained control samples. The number of
events acquired for each sample was 3 x 104. Data shown are the
relative change in mean fluorescence intensity as compared to the
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demonstrates the expression of influenza A PR8 HA pro-
tein on the cell surface of the cell. At 24 hrs post trans-
fection, 40% of the cells are expressing HA on the cell
surface. Transfected cells were stained and examined
alongside untransfected (transfection media alone) and
unstained cells. A small amount of autofluorescence is
seen in these cells and is evidenced by the small peak to
the right of the unstained control. Similar transfections
have been conducted with proteins from rotavirus, HIV
and influenza with efficiencies in the 40-70% range
(data not shown).Figure 6 Phagocytic uptake and binding of pHrodo-labeled-S.
aureus and GFP-Candida albicans. 43MR cells (1 x 106) were
seeded in 6-well tissue culture dishes and incubated with either
GFP-labeled Candida albicans or pHrodo Staphylococcus aureus for
30 minutes at 37°. Following incubation, the cells were washed
twice in PBS and fixed in 2% paraformaldehyde. Following fixation,
the cells were stained for MR using the previously described
monoclonal antibody. Images were collected by confocal
microscopy. N, nucleus. Arrows indicate internalized particles.Discussion
Macrophages are critical members of the innate immune
system, and play a pivotal role in the clearance of patho-
gens, foreign particles and endogenous ligands [18]. One
of these receptors is the MR which recognizes extracellu-
lar host and foreign substances with exposed terminal
mannose residues. Through this binding, the MR med-
iates the internalization of a wide range of pathogens and
host-derived molecules; participates in the resolution of
inflammation; and mediates clearance of apoptotic cells,
endogenous hydrolases, and peroxidases [6,57,68]. In this
study we have demonstrated that 43MR macrophage
hybridoma cells express the 175 kDa MR. This MR
appears to function similarly to the receptor in primary
macrophages and is regulated by agents known to affect
the expression of the MR [39,69,70]. To our knowledge
this is the first description of a continuous human
macrophage cell line that expresses a functional MR.Several continuous monocyte and macrophages lines
currently exist that have been used to study macrophage
biology including HL60, U937, THP-1, and MonoMac
cells [71-74]. The cell surface marker profile of these cell
types varies substantially and none express the exact
Figure 7 Transient transfection of influenza A hemagglutinin in
43MR cells. 43MR cells (1 x 106) were seeded in 6-well culture dishes
and transfected with 5 μg of Influenza A PR8 HA expressing plasmid.
Cells were then incubated for 24 hours at 37. Following incubation,
the cells were harvested and stained for flow cytometry with Alexa
488 conjugated anti-HA (red line). Cells were also harvested for
unstained (shaded gray) and transfection media alone control
samples (blue line). The number of events acquired for each sample
was 3 x 104. Data shown are the mean fluorescence intensity as
compared to the unstained and transfection media alone control.
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macrophage. One disadvantage of using these cell types
as surrogates for primary macrophages is that none ex-
press the MR, and this lack of an appropriate cell line
has limited the study of MR biology in human systems.
Much of the work that has been carried out has been
performed in rat or murine macrophage cell lines that
may or may not represent an accurate picture of the
biology of the receptor in humans [45,49,75]. The paren-
tal 43 hybridoma cell line was described by Sperber et al.
[54] and was created by fusion of the U937 macrophage
continuous cell line with primary monocyte-derived
macrophages. The resultant cells expressed donor-
derived MHC I molecules and several other macrophage
cell surface markers, but did not express detectable
levels of the MR. In the current study, cells were grown
to high confluence and cell sorting was used to select a
subpopulation of cells expressing very low levels of MR.
After successive sorts we ultimately obtained a population
of cells in which >95% of the cells were MR-positive,
and capable of being passaged with high MR mainten-
ance. The isolation and characterization of these cells issignificant for extending the characterization of the MR
to human systems.
In the current study several experimental methods
were employed to demonstrate that the MR in 43MR
cells is equivalent to the 175 kDa MR found in primary
human and rodent macrophages. First, using PCR pro-
ducts were amplified from both the N- and C-terminal
regions of the MR, indicating that these cells express
functional domains important in ligand binding and
receptor-ligand trafficking. Second, in immunoblot ana-
lysis using polyclonal anti-MR antibodies, a 175 kDa MR
was observed as previously reported for the rat and
human MR [49,76]. These findings are consistent with
observations suggesting that concentrations of MR in ro-
dent macrophages can be as much as 10 times greater
than those found in human. Third, confocal imaging
demonstrated a receptor expressed on the surface and in
cytoplasmic compartments that is consistent with previ-
ous descriptions of MR localization [77]. In addition to
immunoblot analysis illustrating a receptor of the same
molecular weight and cellular distribution seen by con-
focal analysis, data from the surface binding and uptake
assays showed ligand binding and internalization equiva-
lent to results previously reported for primary human
macrophages [31].
Another well-documented property of the MR is the
correlation of expression with the functional state of
the macrophage. Previous studies have shown that
agents and cytokines such as dexamethasone, IL-4 and
GM-CSF that promote a mature “deactivated” macro-
phage phenotype result in the induction of MR expres-
sion and altered MR. For example, Cowan et al.
reported that treatment with dexamethasone increased
MR expression on rodent macrophages by as much as
2.5 fold in a time and dose-dependent fashion [69].
Chakraborty et al. reported that dexamethasone-
induced increases in the MR resulted in increased up-
take of Leishmania parasites [29], and Zhu et al.
demonstrated that dexamethasone treatment increased
clearance of glucocerebrocidase by the MR [78]. In
data not presented, we examined the effect of positive
regulators (dexamethasone, GM-CSF, and IL-4) on MR
expression in 43MR cells. Dexamethasone at 0.1 μg/ml
increased MR expression to approximately 130% of
control, slightly under the previously reported increase
seen in rat macrophages (150-200%: [42,69]). These
results suggest that the MR in 43MR cells can be posi-
tively regulated by dexamethasone as previously
reported, and therefore provide further evidence that
the MR expressed by 43MR cells is functionally similar
to the MR found in primary human macrophages.
The macrophage MR plays a key role in a number of
innate host defense activities, including mediating entry
of a variety of important human pathogens and clearance
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we demonstrated that two particle ligands previously
shown to be internalized via the MR - C. albicans and
the Gram positive bacteria S. aureus – were internalized
by 43MR cells, suggesting that the MR on these cells func-
tions as a phagocytic receptor for these organisms.
Finally, we demonstrate the capacity of these cells to
express exogenous proteins via transient transfection. In
this study and in others we have successfully transiently
expressed viral proteins into these cells using several dif-
ferent transfection preparations. The capacity for transi-
ent transfection allows for the introduction of proteins
to study MR trafficking and its interaction with patho-
gen proteins.
Conclusions
Understanding the molecular and cell biology of this re-
ceptor could be key to developing strategies for contain-
ing infection and controlling inflammation. However,
lack of appropriate human cellular models that are avail-
able in large numbers and easily transfectable has ham-
pered progress in this area. In the current study we have
described a new human macrophage cell line developed
by fusion of a human monocytic cell line (U937) and
human monocyte-derived macrophages that express a
functional MR on its surface, binds traditional MR
ligands, and internalizes these ligands appropriately. In
addition these cells can be transfected to a high effi-
ciency, and are capable of expressing high levels of ex-
ogenous DNA. These cells therefore provide a powerful
tool for the study of MR biology with respect to its role
in innate immunity, and the role of the MR and the
macrophage in the pathogenesis of disease.
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